Alpha Cognition Inc. (ACOGF)
- Business Wire
Alpha Cognition Announces Cancelation and Grant of Stock Options
VANCOUVER, British Columbia, January 19, 2023--Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) ("Alpha Cognition", or the "Company"), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, announced today that it has cancelled an aggregate of 4,655,000 incentive stock options with exercise prices ranging from $0.64 CAD to $1.05 CAD. The board of directors (the "Board") has also appro
- Business Wire
Alpha Cognition Announces the Resignation of Chief Medical Officer Cedric O’Gorman, MD
VANCOUVER, British Columbia, January 06, 2023--Alpha Cognition Inc. (TSX-V: ACOG)(OTCQB: ACOGF)("Alpha Cognition", or the "Company"), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, today announced that the company's Chief Medical Officer (CMO), Cedric O’Gorman, MD has resigned to pursue other opportunities. The company has undertaken a search for a replacement for Dr. O’Gorman
- Simply Wall St.
Alpha Cognition Inc. (CVE:ACOG): Are Analysts Optimistic?
With the business potentially at an important milestone, we thought we'd take a closer look at Alpha Cognition Inc.'s...
